Brief: Lee's Pharmaceutical FY Profit Attributable HK$1.99 Bln
29/03/2022 09:42
March 29 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* RECOMMENDS FINAL DIVIDEND OF HK3.1 CENTS PER ORDINARY
SHARE
* FY REVENUE HK$1.27 BILLION VERSUS HK$1.22 BILLION
* FY PROFIT ATTRIBUTABLE HK$1.99 BILLION VERSUS HK$129.3
MILLION
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA